Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications

被引：30

作者：

Butchart, Joseph ^{[1
]}

Holmes, Clive ^{[1
]}

机构：

[1] Univ Southampton, Moorgreen Hosp, Clin Neurosci Div, Southampton, Hants, England

来源：

CNS NEUROSCIENCE & THERAPEUTICS | 2012年 / 18卷 / 01期

关键词：

Alzheimer's disease; Astrocytes; Blood brain barrier; Microglial cells; NECROSIS-FACTOR-ALPHA; AMYLOID-BETA-PEPTIDE; BLOOD-BRAIN-BARRIER; C-REACTIVE PROTEIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MILD COGNITIVE IMPAIRMENT; CENTRAL-NERVOUS-SYSTEM; ACTIVATED-RECEPTOR-GAMMA; PLACEBO-CONTROLLED TRIAL; GENOME-WIDE ASSOCIATION;

D O I：

10.1111/j.1755-5949.2011.00245.x

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Clinical pharmaceutical trials aimed at modulating the immune system in Alzheimer's Disease have largely focused on either dampening down central proinflammatory innate immunity or have manipulated adaptive immunity to facilitate the removal of centrally deposited beta amyloid. To date, these trials have had mixed clinical therapeutic effects. However, a number of clinical studies have demonstrated disturbances of both systemic and central innate immunity in Alzheimer's Disease and attention has been drawn to the close communication pathways between central and systemic immunity. This paper highlights the need to take into account the potential systemic effects of drugs aimed at modulating central immunity and the possibility of developing novel therapeutic approaches based on the manipulation of systemic immunity and its communication with the central nervous system.

引用

页码：64 / 76

页数：13

共 213 条

[11] PK ('peripheral benzodiazepine') - Binding sites in the CNS indicate early and discrete brain lesions: Microautoradiographic detection of [H-3]PK11195 binding to activated microglia [J].

Banati, RB ;

Myers, R ;

Kreutzberg, GW .

JOURNAL OF NEUROCYTOLOGY, 1997, 26 (02) :77-82

[12] CD200 and membrane protein E interactions in the control of myeloid cells [J].

Barclay, AN ;

Wright, GJ ;

Brooke, G ;

Brown, MH .

TRENDS IN IMMUNOLOGY, 2002, 23 (06) :285-290

[13] Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].

Bard, F ;

Cannon, C ;

Barbour, R ;

Burke, RL ;

Games, D ;

Grajeda, H ;

Guido, T ;

Hu, K ;

Huang, JP ;

Johnson-Wood, K ;

Khan, K ;

Kholodenko, D ;

Lee, M ;

Lieberburg, I ;

Motter, R ;

Nguyen, M ;

Soriano, F ;

Vasquez, N ;

Weiss, K ;

Welch, B ;

Seubert, P ;

Schenk, D ;

Yednock, T .

NATURE MEDICINE, 2000, 6 (08) :916-919

[14] Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E [J].

Barger, SW ;

Harmon, AD .

NATURE, 1997, 388 (6645) :878-881

[15] Immune response to Aβ-peptides in peripheral blood from patients with Alzheimer's disease and control subjects [J].

Baril, L ;

Nicolas, L ;

Croisile, B ;

Crozier, P ;

Hessler, C ;

Sassolas, A ;

McCormick, JB ;

Trannoy, E .

NEUROSCIENCE LETTERS, 2004, 355 (03) :226-230

[16] Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease [J].

Baum, Larry ;

Lam, Christopher Wai Kei ;

Cheung, Stanley Kwok-Kuen ;

Kwok, Timothy ;

Lui, Victor ;

Tsoh, Joshua ;

Lam, Linda ;

Leung, Vivian ;

Hui, Elsie ;

Ng, Chelsia ;

Woo, Jean ;

Chiu, Helen Fung Kum ;

Goggins, William B. ;

Zee, Benny Chung-Ying ;

Cheng, King Fai ;

Fong, Carmen Yuet Shim ;

Wong, Adrian ;

Mok, Hazel ;

Chow, Moses Sing Sum ;

Ho, Ping Chuen ;

Ip, Siu Po ;

Ho, Chung Shun ;

Yu, Xiong Wen ;

Lai, Caroline Yau Lin ;

Chan, Ming-Houng ;

Szeto, Samuel ;

Chan, Iris Hiu Shuen ;

Mok, Vincent .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (01) :110-113

[17] Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD [J].

Bayer, AJ ;

Bullock, R ;

Jones, RW ;

Wilkinson, D ;

Paterson, KR ;

Jenkins, L ;

Millais, SB ;

Donoghue, S .

NEUROLOGY, 2005, 64 (01) :94-101

[18] Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease [J].

Begum, Aynun N. ;

Jones, Mychica R. ;

Lim, Giselle P. ;

Morihara, Takashi ;

Kim, Peter ;

Heath, Dennis D. ;

Rock, Cheryl L. ;

Pruitt, Mila A. ;

Yang, Fusheng ;

Hudspeth, Beverly ;

Hu, Shuxin ;

Faull, Kym F. ;

Teter, Bruce ;

Cole, Greg M. ;

Frautschy, Sally A. .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 326 (01) :196-208

[19] Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease [J].

Bermejo, Paloma ;

Martin-Aragon, Sagrario ;

Benedi, Juana ;

Susin, Cristina ;

Felici, Ernanuela ;

Gil, Pedro ;

Ribera, Jose Manuel ;

Villar, Angel M. .

IMMUNOLOGY LETTERS, 2008, 117 (02) :198-202

[20] Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia [J].

Bi, XN ;

Baudry, M ;

Liu, JH ;

Yao, YQ ;

Fu, L ;

Brucher, F ;

Lynch, G .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (46) :48238-48245

← 1 2 3 4 5 6 7 8 9 10 →